Release of 3H-amezinium from cortical noradrenergic axons: a model for the study of the α-autoreceptor hypothesis
1 [ 3 H]-amezinium is taken up selectively into noradrenergic axons and their transmitter-storing vesicles and is released from these axons by action potentials. We used it as a non-α-adrenergic marker in order to study the α-adrenergic autoinhibition of noradrenaline release. 2 Rat occipitocortical...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 1983-04, Vol.78 (4), p.645-653 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 653 |
---|---|
container_issue | 4 |
container_start_page | 645 |
container_title | British journal of pharmacology |
container_volume | 78 |
creator | Hedler, Liselotte Starke, Klaus Steppeler, Anton |
description | 1
[
3
H]-amezinium is taken up selectively into noradrenergic axons and their transmitter-storing vesicles and is released from these axons by action potentials. We used it as a non-α-adrenergic marker in order to study the α-adrenergic autoinhibition of noradrenaline release.
2
Rat occipitocortical slices were preincubated with [
3
H]-amezinium 0.03 μM and then superfused and stimulated electrically (3 Hz for 3 min). The stimulation-evoked overflow of tritium was measured in six groups of slices: from saline-pretreated rats; from saline-pretreated rats, the slices being exposed to exogenous noradrenaline before preincubation with [
3
H]-amezinium; from saline-treated rats, slices from which were exposed simultaneously to noradrenaline and cocaine before preincubation with [
3
H]-amezinium; from rats in which noradrenaline stores had been depleted by pretreatment with α-methyltyrosine (α-MT); from α-MT-treated rats, the slices being exposed to noradrenaline before preincubation with [
3
H]-amezinium; and from α-MT-treated rats, slices from which were exposed to noradrenaline plus cocaine before preincubation with [
3
H]-amezinium.
3
The stimulation-evoked overflow of tritium, expressed as a percentage of the tritium content of the tissue, was 1.15% in slices from saline-pretreated rats, and was similar in slices from saline-pretreated rats after exposure to noradrenaline or noradrenaline plus cocaine. It was 2.56% in slices from α-MT-treated rats, 1.20% from α-MT-treated rats after exposure to noradrenaline, and 2.88% from α-MT-treated rats after exposure to noradrenaline plus cocaine.
4
Yohimbine 0.1 and 1 μM increased the stimulation-evoked overflow of tritium in slices from all groups of saline-pretreated rats and in those slices from α-MT rats that had been in contact with exogenous noradrenaline. Yohimbine did not change the evoked overflow in slices from α-MT rats that had not been exposed to noradrenaline, or had been exposed to noradrenaline plus cocaine.
5
Clonidine 0.01-1 μM decreased the stimulation-evoked overflow of tritium moderately in slices from saline-pretreated rats, markedly in slices from α-MT-treated rats, and moderately again when the latter slices had been exposed to noradrenaline.
6
It is concluded that the action potential-evoked release of [
3
H]-amezinium as well as the modulation of this release by yohimbine and clonidine depend on the presence or absence of α-adrenergic autoinhibition caused by the co-secretion of noradrenalin |
format | Article |
fullrecord | <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2044756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_2044756</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_20447563</originalsourceid><addsrcrecordid>eNqljEFOwzAQRb0AlQK9w1wgkoPTJuqCDQJ1jdhbgzNpjGxPNHYQ4VZchDPRSmxYs3r6_0nvQq211m1V1113pa5zftO6btp2u1KrndGm6cxayTMFwkzAA5hDhZE-ffJzhEE4gmMp3mGAxIK9UCI5egf4wSnvASFyTwEGFigjQS5zv5xD5_H9VeFcWMjRdAKMy8SnP_t8qy4HDJk2v7xR90-PLw-HappfI_WOUhEMdhIfURbL6O1fk_xoj_xu73TTtNud-XfgB1W8ZH8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Release of 3H-amezinium from cortical noradrenergic axons: a model for the study of the α-autoreceptor hypothesis</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Hedler, Liselotte ; Starke, Klaus ; Steppeler, Anton</creator><creatorcontrib>Hedler, Liselotte ; Starke, Klaus ; Steppeler, Anton</creatorcontrib><description>1
[
3
H]-amezinium is taken up selectively into noradrenergic axons and their transmitter-storing vesicles and is released from these axons by action potentials. We used it as a non-α-adrenergic marker in order to study the α-adrenergic autoinhibition of noradrenaline release.
2
Rat occipitocortical slices were preincubated with [
3
H]-amezinium 0.03 μM and then superfused and stimulated electrically (3 Hz for 3 min). The stimulation-evoked overflow of tritium was measured in six groups of slices: from saline-pretreated rats; from saline-pretreated rats, the slices being exposed to exogenous noradrenaline before preincubation with [
3
H]-amezinium; from saline-treated rats, slices from which were exposed simultaneously to noradrenaline and cocaine before preincubation with [
3
H]-amezinium; from rats in which noradrenaline stores had been depleted by pretreatment with α-methyltyrosine (α-MT); from α-MT-treated rats, the slices being exposed to noradrenaline before preincubation with [
3
H]-amezinium; and from α-MT-treated rats, slices from which were exposed to noradrenaline plus cocaine before preincubation with [
3
H]-amezinium.
3
The stimulation-evoked overflow of tritium, expressed as a percentage of the tritium content of the tissue, was 1.15% in slices from saline-pretreated rats, and was similar in slices from saline-pretreated rats after exposure to noradrenaline or noradrenaline plus cocaine. It was 2.56% in slices from α-MT-treated rats, 1.20% from α-MT-treated rats after exposure to noradrenaline, and 2.88% from α-MT-treated rats after exposure to noradrenaline plus cocaine.
4
Yohimbine 0.1 and 1 μM increased the stimulation-evoked overflow of tritium in slices from all groups of saline-pretreated rats and in those slices from α-MT rats that had been in contact with exogenous noradrenaline. Yohimbine did not change the evoked overflow in slices from α-MT rats that had not been exposed to noradrenaline, or had been exposed to noradrenaline plus cocaine.
5
Clonidine 0.01-1 μM decreased the stimulation-evoked overflow of tritium moderately in slices from saline-pretreated rats, markedly in slices from α-MT-treated rats, and moderately again when the latter slices had been exposed to noradrenaline.
6
It is concluded that the action potential-evoked release of [
3
H]-amezinium as well as the modulation of this release by yohimbine and clonidine depend on the presence or absence of α-adrenergic autoinhibition caused by the co-secretion of noradrenaline. When there is co-secretion of noradrenaline, the evoked release of [
3
H]-amezinium is relatively small, yohimbine increases the release, and clonidine can cause only moderate inhibition. When there is no or very little co-secretion of noradrenaline, the evoked release of [
3
H]-amezinium is at least doubled, yohimbine causes no further increase and clonidine produces strong inhibition.</description><identifier>ISSN: 0007-1188</identifier><identifier>PMID: 6303483</identifier><language>eng</language><ispartof>British journal of pharmacology, 1983-04, Vol.78 (4), p.645-653</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2044756/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2044756/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,53766,53768</link.rule.ids></links><search><creatorcontrib>Hedler, Liselotte</creatorcontrib><creatorcontrib>Starke, Klaus</creatorcontrib><creatorcontrib>Steppeler, Anton</creatorcontrib><title>Release of 3H-amezinium from cortical noradrenergic axons: a model for the study of the α-autoreceptor hypothesis</title><title>British journal of pharmacology</title><description>1
[
3
H]-amezinium is taken up selectively into noradrenergic axons and their transmitter-storing vesicles and is released from these axons by action potentials. We used it as a non-α-adrenergic marker in order to study the α-adrenergic autoinhibition of noradrenaline release.
2
Rat occipitocortical slices were preincubated with [
3
H]-amezinium 0.03 μM and then superfused and stimulated electrically (3 Hz for 3 min). The stimulation-evoked overflow of tritium was measured in six groups of slices: from saline-pretreated rats; from saline-pretreated rats, the slices being exposed to exogenous noradrenaline before preincubation with [
3
H]-amezinium; from saline-treated rats, slices from which were exposed simultaneously to noradrenaline and cocaine before preincubation with [
3
H]-amezinium; from rats in which noradrenaline stores had been depleted by pretreatment with α-methyltyrosine (α-MT); from α-MT-treated rats, the slices being exposed to noradrenaline before preincubation with [
3
H]-amezinium; and from α-MT-treated rats, slices from which were exposed to noradrenaline plus cocaine before preincubation with [
3
H]-amezinium.
3
The stimulation-evoked overflow of tritium, expressed as a percentage of the tritium content of the tissue, was 1.15% in slices from saline-pretreated rats, and was similar in slices from saline-pretreated rats after exposure to noradrenaline or noradrenaline plus cocaine. It was 2.56% in slices from α-MT-treated rats, 1.20% from α-MT-treated rats after exposure to noradrenaline, and 2.88% from α-MT-treated rats after exposure to noradrenaline plus cocaine.
4
Yohimbine 0.1 and 1 μM increased the stimulation-evoked overflow of tritium in slices from all groups of saline-pretreated rats and in those slices from α-MT rats that had been in contact with exogenous noradrenaline. Yohimbine did not change the evoked overflow in slices from α-MT rats that had not been exposed to noradrenaline, or had been exposed to noradrenaline plus cocaine.
5
Clonidine 0.01-1 μM decreased the stimulation-evoked overflow of tritium moderately in slices from saline-pretreated rats, markedly in slices from α-MT-treated rats, and moderately again when the latter slices had been exposed to noradrenaline.
6
It is concluded that the action potential-evoked release of [
3
H]-amezinium as well as the modulation of this release by yohimbine and clonidine depend on the presence or absence of α-adrenergic autoinhibition caused by the co-secretion of noradrenaline. When there is co-secretion of noradrenaline, the evoked release of [
3
H]-amezinium is relatively small, yohimbine increases the release, and clonidine can cause only moderate inhibition. When there is no or very little co-secretion of noradrenaline, the evoked release of [
3
H]-amezinium is at least doubled, yohimbine causes no further increase and clonidine produces strong inhibition.</description><issn>0007-1188</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><recordid>eNqljEFOwzAQRb0AlQK9w1wgkoPTJuqCDQJ1jdhbgzNpjGxPNHYQ4VZchDPRSmxYs3r6_0nvQq211m1V1113pa5zftO6btp2u1KrndGm6cxayTMFwkzAA5hDhZE-ffJzhEE4gmMp3mGAxIK9UCI5egf4wSnvASFyTwEGFigjQS5zv5xD5_H9VeFcWMjRdAKMy8SnP_t8qy4HDJk2v7xR90-PLw-HappfI_WOUhEMdhIfURbL6O1fk_xoj_xu73TTtNud-XfgB1W8ZH8</recordid><startdate>19830401</startdate><enddate>19830401</enddate><creator>Hedler, Liselotte</creator><creator>Starke, Klaus</creator><creator>Steppeler, Anton</creator><scope>5PM</scope></search><sort><creationdate>19830401</creationdate><title>Release of 3H-amezinium from cortical noradrenergic axons: a model for the study of the α-autoreceptor hypothesis</title><author>Hedler, Liselotte ; Starke, Klaus ; Steppeler, Anton</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_20447563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hedler, Liselotte</creatorcontrib><creatorcontrib>Starke, Klaus</creatorcontrib><creatorcontrib>Steppeler, Anton</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hedler, Liselotte</au><au>Starke, Klaus</au><au>Steppeler, Anton</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Release of 3H-amezinium from cortical noradrenergic axons: a model for the study of the α-autoreceptor hypothesis</atitle><jtitle>British journal of pharmacology</jtitle><date>1983-04-01</date><risdate>1983</risdate><volume>78</volume><issue>4</issue><spage>645</spage><epage>653</epage><pages>645-653</pages><issn>0007-1188</issn><abstract>1
[
3
H]-amezinium is taken up selectively into noradrenergic axons and their transmitter-storing vesicles and is released from these axons by action potentials. We used it as a non-α-adrenergic marker in order to study the α-adrenergic autoinhibition of noradrenaline release.
2
Rat occipitocortical slices were preincubated with [
3
H]-amezinium 0.03 μM and then superfused and stimulated electrically (3 Hz for 3 min). The stimulation-evoked overflow of tritium was measured in six groups of slices: from saline-pretreated rats; from saline-pretreated rats, the slices being exposed to exogenous noradrenaline before preincubation with [
3
H]-amezinium; from saline-treated rats, slices from which were exposed simultaneously to noradrenaline and cocaine before preincubation with [
3
H]-amezinium; from rats in which noradrenaline stores had been depleted by pretreatment with α-methyltyrosine (α-MT); from α-MT-treated rats, the slices being exposed to noradrenaline before preincubation with [
3
H]-amezinium; and from α-MT-treated rats, slices from which were exposed to noradrenaline plus cocaine before preincubation with [
3
H]-amezinium.
3
The stimulation-evoked overflow of tritium, expressed as a percentage of the tritium content of the tissue, was 1.15% in slices from saline-pretreated rats, and was similar in slices from saline-pretreated rats after exposure to noradrenaline or noradrenaline plus cocaine. It was 2.56% in slices from α-MT-treated rats, 1.20% from α-MT-treated rats after exposure to noradrenaline, and 2.88% from α-MT-treated rats after exposure to noradrenaline plus cocaine.
4
Yohimbine 0.1 and 1 μM increased the stimulation-evoked overflow of tritium in slices from all groups of saline-pretreated rats and in those slices from α-MT rats that had been in contact with exogenous noradrenaline. Yohimbine did not change the evoked overflow in slices from α-MT rats that had not been exposed to noradrenaline, or had been exposed to noradrenaline plus cocaine.
5
Clonidine 0.01-1 μM decreased the stimulation-evoked overflow of tritium moderately in slices from saline-pretreated rats, markedly in slices from α-MT-treated rats, and moderately again when the latter slices had been exposed to noradrenaline.
6
It is concluded that the action potential-evoked release of [
3
H]-amezinium as well as the modulation of this release by yohimbine and clonidine depend on the presence or absence of α-adrenergic autoinhibition caused by the co-secretion of noradrenaline. When there is co-secretion of noradrenaline, the evoked release of [
3
H]-amezinium is relatively small, yohimbine increases the release, and clonidine can cause only moderate inhibition. When there is no or very little co-secretion of noradrenaline, the evoked release of [
3
H]-amezinium is at least doubled, yohimbine causes no further increase and clonidine produces strong inhibition.</abstract><pmid>6303483</pmid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 1983-04, Vol.78 (4), p.645-653 |
issn | 0007-1188 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2044756 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
title | Release of 3H-amezinium from cortical noradrenergic axons: a model for the study of the α-autoreceptor hypothesis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A17%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Release%20of%203H-amezinium%20from%20cortical%20noradrenergic%20axons:%20a%20model%20for%20the%20study%20of%20the%20%CE%B1-autoreceptor%20hypothesis&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Hedler,%20Liselotte&rft.date=1983-04-01&rft.volume=78&rft.issue=4&rft.spage=645&rft.epage=653&rft.pages=645-653&rft.issn=0007-1188&rft_id=info:doi/&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_2044756%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/6303483&rfr_iscdi=true |